MENU
+Compare
NEUP
Stock ticker: NASDAQ
AS OF
Jun 6, 04:38 PM (EDT)
Price
$6.88
Change
-$0.27 (-3.78%)
Capitalization
25.08M

NEUP Neuphoria Therapeutics Inc Forecast, Technical & Fundamental Analysis

Neuphoria Therapeutics Inc is a clinical stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders... Show more

NEUP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for NEUP with price predictions
Jun 05, 2025

NEUP in upward trend: 10-day moving average broke above 50-day moving average on May 23, 2025

The 10-day moving average for NEUP crossed bullishly above the 50-day moving average on May 23, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on May 20, 2025. You may want to consider a long position or call options on NEUP as a result. In of 66 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for NEUP just turned positive on May 20, 2025. Looking at past instances where NEUP's MACD turned positive, the stock continued to rise in of 38 cases over the following month. The odds of a continued upward trend are .

NEUP moved above its 50-day moving average on May 20, 2025 date and that indicates a change from a downward trend to an upward trend.

The 50-day moving average for NEUP moved above the 200-day moving average on May 05, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NEUP advanced for three days, in of 132 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 9 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 9 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NEUP declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

NEUP broke above its upper Bollinger Band on May 20, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.517) is normal, around the industry mean (16.332). P/E Ratio (0.380) is within average values for comparable stocks, (59.787). NEUP's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.227). Dividend Yield (0.000) settles around the average of (0.040) among similar stocks. P/S Ratio (68.493) is also within normal values, averaging (263.647).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NEUP’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NEUP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
NEUP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SMG65.016.39
+10.90%
Scotts Miracle-Gro Company (The)
PRM12.650.40
+3.27%
Perimeter Solutions Inc
WIT2.860.02
+0.70%
Wipro Limited
OCX2.93N/A
N/A
Oncocyte Corp
PBFS11.31-0.08
-0.70%
Pioneer Bancorp

NEUP and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NEUP has been loosely correlated with SYBX. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if NEUP jumps, then SYBX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEUP
1D Price
Change %
NEUP100%
N/A
SYBX - NEUP
64%
Loosely correlated
-0.81%
BRNS - NEUP
50%
Loosely correlated
-8.33%
CMND - NEUP
31%
Poorly correlated
+0.65%
ENSC - NEUP
31%
Poorly correlated
-2.31%
SLNO - NEUP
27%
Poorly correlated
-2.47%
More